Morgan Stanley’s LifeMD LFMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.7M | Buy |
1,593,282
+847,262
| +114% | +$11.5M | ﹤0.01% | 2720 |
|
|
2025
Q1 | $4.06M | Buy |
746,020
+327,330
| +78% | +$1.78M | ﹤0.01% | 4100 |
|
|
2024
Q4 | $2.07M | Buy |
418,690
+80,039
| +24% | +$396K | ﹤0.01% | 4674 |
|
|
2024
Q3 | $1.77M | Sell |
338,651
-287,843
| -46% | -$1.51M | ﹤0.01% | 4728 |
|
|
2024
Q2 | $4.3M | Buy |
626,494
+40,432
| +7% | +$277K | ﹤0.01% | 4007 |
|
|
2024
Q1 | $6.02M | Sell |
586,062
-105,056
| -15% | -$1.08M | ﹤0.01% | 3770 |
|
|
2023
Q4 | $5.73M | Buy |
691,118
+543,344
| +368% | +$4.5M | ﹤0.01% | 4289 |
|
|
2023
Q3 | $924K | Buy |
147,774
+122,140
| +476% | +$763K | ﹤0.01% | 4846 |
|
|
2023
Q2 | $112K | Buy |
25,634
+21,500
| +520% | +$93.5K | ﹤0.01% | 5901 |
|
|
2023
Q1 | $7.03K | Sell |
4,134
-3,257
| -44% | -$5.54K | ﹤0.01% | 6981 |
|
|
2022
Q4 | $14.3K | Sell |
7,391
-5,139
| -41% | -$9.97K | ﹤0.01% | 6811 |
|
|
2022
Q3 | $24K | Sell |
12,530
-10,830
| -46% | -$20.7K | ﹤0.01% | 6714 |
|
|
2022
Q2 | $48K | Sell |
23,360
-5,976
| -20% | -$12.3K | ﹤0.01% | 6631 |
|
|
2022
Q1 | $103K | Sell |
29,336
-18,205
| -38% | -$63.9K | ﹤0.01% | 6287 |
|
|
2021
Q4 | $184K | Sell |
47,541
-18,795
| -28% | -$72.7K | ﹤0.01% | 6119 |
|
|
2021
Q3 | $412K | Buy |
66,336
+33,424
| +102% | +$208K | ﹤0.01% | 5611 |
|
|
2021
Q2 | $387K | Buy |
32,912
+16,895
| +105% | +$199K | ﹤0.01% | 5684 |
|
|
2021
Q1 | $253K | Buy |
16,017
+8,134
| +103% | +$128K | ﹤0.01% | 5521 |
|
|
2020
Q4 | $51K | Buy |
+7,883
| New | +$51K | ﹤0.01% | 6155 |
|